J9264 Paclitaxel protein bound
Also known as: abraxane, nab-paclitaxel, protein-bound paclitaxel
Injection of paclitaxel protein-bound formulation (Abraxane). A microtubule-stabilizing agent nanoparticle albumin-bound to paclitaxel.
In Plain Language
breast cancer chemotherapy; albumin-bound cancer drug
Clinical Context
Used for metastatic breast cancer, non-small cell lung cancer, and pancreatic cancer. Preferred over standard paclitaxel in patients with neuropathy risk or hypersensitivity concerns.
RVU Information
CPT J9264 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9264?
CPT J9264 (Paclitaxel protein bound) is a J Codes (Drugs) code. Injection of paclitaxel protein-bound formulation (Abraxane). A microtubule-stabilizing agent nanoparticle albumin-bound to paclitaxel.
How is J9264 administered?
CPT J9264 is administered by a healthcare provider, typically via injection or infusion. Used for metastatic breast cancer, non-small cell lung cancer, and pancreatic cancer. Preferred over standard paclitaxel in patients with neuropathy risk or hypersensitivity concerns. It is used by Oncology, Pulmonology, Surgery.
When is CPT J9264 used?
Used for metastatic breast cancer, non-small cell lung cancer, and pancreatic cancer. Preferred over standard paclitaxel in patients with neuropathy risk or hypersensitivity concerns.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.